Finding Inhibitors for a Cancer Target: CDK12 Activity Assays Accelerate the Search
Tuesday, 03 December 2019
All systems within our bodies function by means of proteins. When these proteins aren’t made correctly, our body malfunctions. The short explanation: DNA is at the fabric of forming a functional protein; genes (made of DNA) get transcribed and then translated to become proteins. During this complex process, genes are not always correctly transcribed and
- Published in Emerging Targets, HTS Assays
No Comments
Using TBK1 Inhibitors to Stop Cancer in Its Tracks
Tuesday, 29 October 2019
TBK1 Inhibitors, Autoimmune Disorders, and Cancer – Inflammation is a crucial step within the immune response, helping our bodies eliminate disease. However, it can also be a burden where misregulation creates a variety of maladies including cancer. As inflammation persists, becoming chronic, the beneficial elements can be lost and disease occurs. It’s not just autoimmune
- Published in Emerging Targets
How a Tyrosine Kinase Inhibitor Is Giving Hope to Lung Cancer Patients
Tuesday, 20 August 2019
According to the American Cancer Society, lung cancer is the leading cause of cancer death each year and accounts for approximately 13% of all new cases. The most common type being non-small cell lung cancer (NSCLC). Although smoking is the biggest contributor, other factors such as genetics and environmental pollutants contribute to lung cancer of
- Published in Emerging Targets
How Does a Biochemical Kinase Assay Work?
Monday, 10 December 2018
A kinase assay works by simply measuring the activity of the kinase. A kinase is an enzyme that aids in the transfer of a phosphate from ATP to another specific molecule. They regulate many activities in the human body. The measurement is used to test potential drugs to see how they affect kinase activity. An
- Published in HTS Assays
Doubling the Odds: Two-Pronged Strategy to Halt Cancer Cell Proliferation
Wednesday, 29 November 2017
It would be difficult to underestimate the importance of polo-like kinase 1 (Plk1) for cancer, given its influence on cell division. As one of five members of the Polo-like family of serine/threonine protein kinases in eukaryotic cells, Plk1 plays a multifaceted role in the cell cycle and thus controls cancer progression fueled by unchecked cell
- Published in HTS Assays, News, Uncategorized
Taking Up Residence: Using the Transcreener ADP Assay to Measure the Kinetics of Kinase Inhibitor Interactions
Wednesday, 30 August 2017
Classically speaking, assays for interactions between drug molecules and their targets have measured binding affinity under equilibrium conditions. In drug discovery projects, it had long been assumed that carefully measuring IC50 (half-maximal inhibitory concentration), EC50 (effector concentration for half-maximal response), Kd (equilibrium dissociation constant), and/or Ki (inhibition constant) would allow drug candidates to be prioritized
- Published in HTS Assays, Uncategorized
Kinase Assays and Applications in Cancer Therapeutic Discovery
Wednesday, 30 November 2016
The ABL1 gene is a special type of gene that encodes a protein tyrosine kinase. It is involved in various cellular processes, including but not limited to cell adhesion, cell division, and cell differentiation. This protein’s activity is adversely regulated by its SH3 domain, which involves the deletion of the region that encodes the domain
- Published in HTS Assays
ICBS Conference 2016
Thursday, 06 October 2016
Location: Madison, WI Date: October 24-26 BellBrook Labs’ team of scientists will be presenting the following posters at the International Chemical Biology Society. A Homogenous, Universal Methyltransferase Assay Based on a Microbial Riboswitch Leveraging Aptamers for Detection of Growth Factors in an HTS Compatible Format: An AptaFluor™ VEGF Assay Measuring Drug Residence Times
- 1
- 2